TLDR cover image

Why Gold Is Going Up

TLDR

00:00

Success of Novo Nordisk's GLP1 Drugs: From Type 2 Diabetes to New Frontiers

Exploring Novo Nordisk's success with GLP1 drugs in treating type 2 diabetes and potential new applications in areas like weight loss and Parkinson's disease. Discussion on market impact, implications for accessibility and affordability, and the optimistic outlook for broad-based supply and cost reduction.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app